Literature DB >> 3143234

Trauma to the corpus callosum: MR features.

L R Gentry1, B Thompson, J C Godersky.   

Abstract

The frequency, distribution, and appearance of corpus callosum injuries were evaluated with MR and CT in a prospective study of 78 patients with acute (n = 63) and chronic (n = 15) head injuries. Traumatic lesions of the corpus callosum were detected in 47% of patients. MR was significantly (p less than .001) more sensitive than CT in the detection of callosal injuries. MR and CT visualized 100% and 27%, respectively, of the traumatic callosal lesions that were detected in the study population. The majority of lesions were located in the splenium but a few were also found in the body and genu. Patients with callosal injuries had a significantly higher incidence of primary brainstem injury (p less than .02) as well as a greater number of subcortical gray-matter (p less than .05) and diffuse axonal "shear" (p less than .001) lesions. In addition, patients with callosal injuries had a significantly higher incidence of traumatic lesions of the septum pellucidum (p less than .007) and fornix (p less than .001). Intraventricular hemorrhage occurred significantly more often (p less than .002) in patients with callosal injuries, especially if traumatic lesions of the fornix or septum pellucidum were also present. Patients with callosal injuries had significantly lower initial Glasgow Coma Scale scores (mean, 6.6) than those without injuries (mean, 10.7) (p less than .001). Injury to the corpus callosum occurs much more often with nonfatal head injuries than had been believed previously.

Entities:  

Mesh:

Year:  1988        PMID: 3143234      PMCID: PMC8331914     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  32 in total

Review 1.  Brain imaging.

Authors:  R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

2.  Diffuse axonal injury associated with chronic traumatic brain injury: evidence from T2*-weighted gradient-echo imaging at 3 T.

Authors:  Rainer Scheid; Cristoph Preul; Oliver Gruber; Christopher Wiggins; D Yves von Cramon
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

Review 3.  [Craniocerebral trauma. 2: Intra-axial injuries, secondary injuries].

Authors:  T Struffert; C Axmann; W Reith
Journal:  Radiologe       Date:  2003-11       Impact factor: 0.635

4.  HM-PAO-SPECT in persistent vegetative state after head injury: prognostic indicator of the likelihood of recovery?

Authors:  W Oder; G Goldenberg; I Podreka; L Deecke
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 5.  Essentials of trauma: head and spine.

Authors:  Handan Cakmakci
Journal:  Pediatr Radiol       Date:  2009-06

Review 6.  Imaging Evaluation of Acute Traumatic Brain Injury.

Authors:  Christopher A Mutch; Jason F Talbott; Alisa Gean
Journal:  Neurosurg Clin N Am       Date:  2016-08-10       Impact factor: 2.509

Review 7.  [Corpus callosum. Landmark of the origin of cerebral diseases].

Authors:  E Hattingen; M Nichtweiss; S Blasel; F E Zanella; S Weidauer
Journal:  Radiologe       Date:  2010-02       Impact factor: 0.635

Review 8.  Head trauma.

Authors:  Patricia C Davis
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

9.  Magnetization transfer imaging and proton MR spectroscopy in the evaluation of axonal injury: correlation with clinical outcome after traumatic brain injury.

Authors:  G Sinson; L J Bagley; K M Cecil; M Torchia; J C McGowan; R E Lenkinski; T K McIntosh; R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 10.  White matter damage after traumatic brain injury: A role for damage associated molecular patterns.

Authors:  Molly Braun; Kumar Vaibhav; Nancy M Saad; Sumbul Fatima; John R Vender; Babak Baban; Md Nasrul Hoda; Krishnan M Dhandapani
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-19       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.